ONEMEDNET CORPORATION Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ONEMEDNET CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $182.00K, a 38.93% decline year-over-year.
- ONEMEDNET CORPORATION stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $298.00K.
- ONEMEDNET CORPORATION stock issued during period, value, conversion of convertible securities for fiscal 2023 was $16.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $182.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $1.39M S-1/A · filed 2026-07-08 | |
| 2025-06-30 | $298.00K 10-Q · filed 2026-08-14 | |
| 2023-12-31 | $16.00K 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |